| abstract |
Disclosed are a compound useful as a triple reuptake inhibitor, a method for producing a composition containing the compound, and a method for using them. A compound represented by formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof. A pharmaceutical composition for treating a central nervous system disease comprising the compound, and a method for using them. (Both m and n are 1 or m is 2 and n is 1; X is H, methyl or ethyl; Y and Z are each independently halogen) |